90 results
8-K
EX-99.1
ABCL
AbCellera Biologics Inc
7 May 24
AbCellera Reports Q1 2024 Business Results
4:22pm
approval is not known to us, the date of the first public announcement of a clinical trial will be used for the purpose of this metric. We view
S-8
ABCL
AbCellera Biologics Inc
20 Feb 24
Registration of securities for employees
4:49pm
solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act, and based on $5.255, the average
8-K
EX-99.1
3t4nzoowey
20 Feb 24
AbCellera Reports Full Year 2023 Business Results
4:27pm
8-K
EX-99.1
w8n60v86p 06
2 Nov 23
Results of Operations and Financial Condition
4:13pm
8-K
EX-99.1
thsukeg15jqi m98c87
3 Aug 23
AbCellera Reports Q2 2023 Business Results
4:15pm
8-K
EX-99.1
l5jtgei2i0gyhs
4 May 23
Results of Operations and Financial Condition
4:39pm
8-K
EX-99.1
ci55w szzzbpxcfu
8 Nov 22
AbCellera Reports Q3 2022 Business Results
4:31pm
POS AM
2zo0ji3u 6skkfbt0y
22 Jul 22
Prospectus update (post-effective amendment)
4:38pm
8-K
EX-10.1
u31j t0aol27ipm6cgz
18 Jul 22
Departure of Directors or Certain Officers
5:42pm